Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Korro Bio, Inc.FREQ · Entity 6388 | VP Finance & Operations | August 18, 2023 | August 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Korro Bio, Inc.
Report date August 18, 2023 · Filed August 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,457 |
Ending reported balance
After 2023-08-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-08-18 · Sale · Disposed 227 · Balance 48,694 F1: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.630 to $0.633. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Row 2 · 2023-08-21 · Sale · Disposed 237 · Balance 48,457 F1: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.530 to $0.540. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| Common StockSEC Table I · non-derivative | IndirectThe Carey/Mitrano Family Trust | 4,032 |
Reported balance
Holding disclosure · report date 2023-08-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,032 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.630 to $0.633. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F3: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.530 to $0.540. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2023 Filed Aug 22, 2023 20:21 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 237 | $0.53 | $125.61 |
DisclosureSEC source: 0001127602-23-023082 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,457 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.530 to $0.540. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 20:21 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 227 | $0.63 | $143.01 |
DisclosureSEC source: 0001127602-23-023082 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,694 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.630 to $0.633. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 12:05 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 230 | $0.62 | $142.60 |
DisclosureSEC source: 0001127602-23-022902 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,921 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.636 to $0.690. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 12:05 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 234 | $0.67 | $156.78 |
DisclosureSEC source: 0001127602-23-022902 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,151 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.670 to $0.680. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 13:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 228 | $0.65 | $148.20 |
DisclosureSEC source: 0001127602-23-022638 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,385 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.636 to $0.668. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 13:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 238 | $0.64 | $152.32 |
DisclosureSEC source: 0001127602-23-022638 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,613 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.635 to $0.652. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 240 | $0.64 | $153.60 |
DisclosureSEC source: 0001127602-23-022478 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,851 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.636 to $0.641. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 10, 2023 Filed Aug 14, 2023 20:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 247 | $0.64 | $158.08 |
DisclosureSEC source: 0001127602-23-022478 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,091 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.642 to $0.661. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 20:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 238 | $0.66 | $157.08 |
DisclosureSEC source: 0001127602-23-022279 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,338 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.660 to $0.662. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 241 | $0.67 | $161.47 |
DisclosureSEC source: 0001127602-23-022279 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,576 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.661 to $0.675. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 07, 2023 Filed Aug 9, 2023 12:50 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 235 | $0.69 | $162.15 |
DisclosureSEC source: 0001127602-23-022218 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,817 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.685 to $0.692. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 04, 2023 Filed Aug 9, 2023 12:50 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 220 | $0.67 | $147.40 |
DisclosureSEC source: 0001127602-23-022218 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,052 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.664 to $0.670. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 03, 2023 Filed Aug 4, 2023 20:09 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 232 | $0.56 | $129.92 |
DisclosureSEC source: 0001127602-23-022007 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,272 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.559 to $0.573. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:09 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 231 | $0.49 | $113.19 |
DisclosureSEC source: 0001127602-23-022007 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,504 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.480 to $0.498. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:35 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 238 | $0.48 | $114.24 |
DisclosureSEC source: 0001127602-23-021842 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,735 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.465 to $0.50. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:35 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 222 | $0.50 | $111.00 |
DisclosureSEC source: 0001127602-23-021842 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,973 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.50 to $0.515. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 28, 2023 Filed Jul 31, 2023 20:09 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 223 | $0.47 | $104.81 |
DisclosureSEC source: 0001127602-23-021563 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,195 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.467 to $0.471. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 20:09 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 227 | $0.53 | $120.31 |
DisclosureSEC source: 0001127602-23-021563 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,418 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.532 to $0.541. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 26, 2023 Filed Jul 27, 2023 20:16 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 222 | $0.53 | $117.66 |
DisclosureSEC source: 0000950170-23-035165 · ownership.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,645 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.511 to $0.541. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:16 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 234 | $0.50 | $117.00 |
DisclosureSEC source: 0000950170-23-035165 · ownership.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,867 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.491 to $0.505 The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 24, 2023 Filed Jul 25, 2023 20:55 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 234 | $0.56 | $131.04 |
DisclosureSEC source: 0000950170-23-034473 · ownership.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,101 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.549 to $0.561. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 20:55 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 223 | $0.61 | $136.25 |
DisclosureSEC source: 0000950170-23-034473 · ownership.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,335 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 20:04 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 229 | $0.64 | $146.56 |
DisclosureSEC source: 0001127602-23-021131 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,558 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.63 to $0.64. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 20:04 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 228 | $0.63 | $143.64 |
DisclosureSEC source: 0001127602-23-021131 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,787 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 20:16 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 249 | $0.56 | $139.44 |
DisclosureSEC source: 0001127602-23-021003 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,015 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:16 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 244 | $0.65 | $158.60 |
DisclosureSEC source: 0001127602-23-021003 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,264 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.62 to $0.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:20 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 148 | $0.60 | $88.80 |
DisclosureSEC source: 0001127602-23-020817 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,508 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.57 to $0.60. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:20 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 227 | $0.39 | $88.53 |
DisclosureSEC source: 0001127602-23-020817 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,656 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.38 to $0.39. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 12, 2023 Filed Jul 13, 2023 20:09 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 220 | $0.40 | $88.00 |
DisclosureSEC source: 0001127602-23-020652 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,883 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.39 to $0.41. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:09 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 228 | $0.37 | $84.36 |
DisclosureSEC source: 0001127602-23-020652 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,103 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 21:29 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020572 · form4.xml · derivative · entry 7 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,968 Underlying: Common Stock · 758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units will fully vest on July 4, 2023. F4 · derivative.expiration_date: The restricted stock units will fully vest on July 4, 2023. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 21:29 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionCommon Stock | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020572 · form4.xml · nonDerivative · entry 4 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| July 10, 2023 Filed Jul 11, 2023 21:29 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 220 | $0.37 | $81.40 |
DisclosureSEC source: 0001127602-23-020572 · form4.xml · nonDerivative · entry 3 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,605 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 10, 2023 Filed Jul 13, 2023 01:25 UTC Amendment | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 220 | $0.37 | $81.40 |
DisclosureSEC source: 0000950170-23-032740 · ownership.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,331 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 21:29 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020572 · form4.xml · derivative · entry 6 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,726 Underlying: Common Stock · 758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units will fully vest on July 4, 2023. F4 · derivative.expiration_date: The restricted stock units will fully vest on July 4, 2023. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 21:29 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionCommon Stock | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020572 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 21:29 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 220 | $0.36 | $79.20 |
DisclosureSEC source: 0001127602-23-020572 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,067 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.35 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 07, 2023 Filed Jul 13, 2023 01:25 UTC Amendment | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 220 | $0.36 | $79.20 |
DisclosureSEC source: 0000950170-23-032740 · ownership.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,551 F1 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.35 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| July 06, 2023 Filed Jul 7, 2023 21:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020481 · form4.xml · derivative · entry 6 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,484 Underlying: Common Stock · 758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will fully vest on July 4, 2023. F3 · derivative.expiration_date: The restricted stock units will fully vest on July 4, 2023. Read SEC document |
| July 06, 2023 Filed Jul 7, 2023 21:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionCommon Stock | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020481 · form4.xml · nonDerivative · entry 3 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| July 06, 2023 Filed Jul 7, 2023 21:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 224 | $0.35 | $78.40 |
DisclosureSEC source: 0001127602-23-020481 · form4.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,529 F2 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 06, 2023 Filed Jul 13, 2023 01:18 UTC Amendment | Korro Bio, Inc. FREQ · Entity 6388 | SaleCommon Stock | 224 | $0.35 | $78.40 |
DisclosureSEC source: 0000950170-23-032732 · ownership.xml · nonDerivative · entry 2 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,771 F2 · shares: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person. Read SEC document |
| July 05, 2023 Filed Jul 7, 2023 21:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020481 · form4.xml · derivative · entry 5 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,242 Underlying: Common Stock · 758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will fully vest on July 4, 2023. F3 · derivative.expiration_date: The restricted stock units will fully vest on July 4, 2023. Read SEC document |
| July 05, 2023 Filed Jul 7, 2023 21:06 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionCommon Stock | 758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-020481 · form4.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| July 04, 2023 Filed Jul 13, 2023 01:18 UTC Amendment | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-032732 · ownership.xml · derivative · entry 4 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The Restricted Stock Units vested on July 4, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The Restricted Stock Units vested on July 4, 2023 and do not have an expiration date. Read SEC document |
| July 04, 2023 Filed Jul 13, 2023 01:18 UTC Amendment | Korro Bio, Inc. FREQ · Entity 6388 | Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-032732 · ownership.xml · nonDerivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 21:40 UTC | Korro Bio, Inc. FREQ · Entity 6388 | GrantRestricted Stock Unit · Derivative | 91,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-002458 · form4.xml · derivative · entry 1 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,000 Underlying: Common Stock · 91,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units will vest in four equal annual installments beginning on January 26, 2024. F2 · derivative.expiration_date: The restricted stock units will vest in four equal annual installments beginning on January 26, 2024. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Disposition to issuerStock Option · Derivative | 11,550 | Not disclosed Strike: $35.85 | Not disclosed |
DisclosureSEC source: 0001127602-22-021372 · form4.xml · derivative · entry 6 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,550 shares Expires 2031-01-14 F2 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options. F4 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | GrantStock Option · Derivative | 11,550 | Not disclosed Strike: $2.14 | Not disclosed |
DisclosureSEC source: 0001127602-22-021372 · form4.xml · derivative · entry 5 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,550 Underlying: Common Stock · 11,550 shares Expires 2031-01-14 F2 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options. F4 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:02 UTC | Korro Bio, Inc. FREQ · Entity 6388 | Disposition to issuerStock Option · Derivative | 18,000 | Not disclosed Strike: $25.05 | Not disclosed |
DisclosureSEC source: 0001127602-22-021372 · form4.xml · derivative · entry 4 Mitrano Richard J. · CIK 0001785287 · VP Finance & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,000 shares Expires 2030-02-11 F2 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options. F3 · derivative.exercise_date: The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2020, and will be fully vested and exercisable on January 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.